Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC trial protocol.
BMJ open（2022）
摘要
EudraCT 2020-001805-21, ISRCTN53038326, NCT04516915.
更多查看译文
关键词
COVID-19,immunology,infectious diseases,public health
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要